Aligos Therapeutics (ALGS) EBITDA Margin (2019 - 2026)
Aligos Therapeutics' EBITDA Margin was -939.33% in Q1 2026, up 5183.82 percentage points from -6123.15% a year earlier and up 11832.27 percentage points from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) EBITDA Margin (2019 - 2026) Analysis & Trends
For FY2025, EBITDA Margin at Aligos Therapeutics came in at -3982.39%, down 1541.87 percentage points from FY2024.
- EBITDA Margin has now declined for three consecutive years, with a four-year change of -1107.83 percentage points (FY2021 to FY2025).
- In earlier years, EBITDA Margin was -2440.52% in FY2024 (-1513.90 pp), -926.61% in FY2023 (-241.53 pp), -685.08% in FY2022 (+2189.48 pp) and -2874.56% in FY2021.
- The Q1 2026 figure marks the highest quarterly EBITDA Margin since Q3 2023.
- Compared with a year earlier, EBITDA Margin was higher in two of the last eight quarters, with an average year-over-year change of -1711.11 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q4 2022 (a gain of 9517.17 percentage points); the worst was Q4 2025 (a drop of 9415.82 percentage points).
- Per Business Quant data, ALGS's EBITDA Margin in the three quarters before Q1 2026 was -12771.60% (Q4 2025), -3800.40% (Q3 2025) and -1892.95% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Aligos Therapeutics | 52.83 Mn | -275.57 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -939.33% |
| Dec 31, 2025 | -12,771.60% |
| Sep 30, 2025 | -3,800.40% |
| Jun 30, 2025 | -1,892.95% |
| Mar 31, 2025 | -6,123.15% |
| Dec 31, 2024 | -3,355.78% |
| Sep 30, 2024 | -1,586.48% |
| Jun 30, 2024 | -2,461.26% |
| Mar 31, 2024 | -3,133.43% |
| Dec 31, 2023 | -1,274.12% |
| Sep 30, 2023 | -871.45% |
| Jun 30, 2023 | -436.45% |
| Mar 31, 2023 | -906.62% |
| Dec 31, 2022 | -626.97% |
| Sep 30, 2022 | -449.29% |
| Jun 30, 2022 | -535.96% |
| Mar 31, 2022 | -1,355.78% |
| Dec 31, 2021 | -10,144.14% |
| Sep 30, 2021 | -2,099.41% |
| Jun 30, 2021 | -1,861.81% |
API Access
Aligos Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();